Numinus Wellness Medical and Therapeutic Services Director for Numinus Dr. Devon Christie joined Steve Darling from Proactive to announce Health Canada has cleared an open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder.
Dr Christie, who will serve as the study’s Qualified Investigator, tells Proactive during the study, research, medical and therapist staff at Numinus will collect data on the safety and effectiveness of MDMA-assisted therapy and then inform Health Canada.